130 related articles for article (PubMed ID: 18951434)
1. Bilateral adrenal neuroblastoma.
Pagès PM; Dufour C; Fasola S; Michon J; Boutard P; Gentet JC; Hartmann O
Pediatr Blood Cancer; 2009 Feb; 52(2):196-202. PubMed ID: 18951434
[TBL] [Abstract][Full Text] [Related]
2. Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.
Bishop MW; Yin H; Shimada H; Towbin AJ; Miethke A; Weiss B
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e31-5. PubMed ID: 23528904
[TBL] [Abstract][Full Text] [Related]
3. Management and outcome of stage 3 neuroblastoma.
Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
[TBL] [Abstract][Full Text] [Related]
4. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
Dinh T; Truong B; Matthay KK; DuBois SG
J Pediatr Hematol Oncol; 2017 Mar; 39(2):108-113. PubMed ID: 27820129
[TBL] [Abstract][Full Text] [Related]
8. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
[TBL] [Abstract][Full Text] [Related]
9. Natural course of low risk neuroblastoma.
Shuangshoti S; Shuangshoti S; Nuchprayoon I; Kanjanapongkul S; Marrano P; Irwin MS; Thorner PS
Pediatr Blood Cancer; 2012 May; 58(5):690-4. PubMed ID: 21922650
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment.
Boztug K; Kiely E; Roebuck DJ; Gaze M; Begent J; Brock P; Michalski A
Pediatr Blood Cancer; 2006 Feb; 46(2):253-7. PubMed ID: 15926157
[TBL] [Abstract][Full Text] [Related]
11. [4S neuroblastoma with bilateral adrenal tumors].
Kerdudo C; Corradini N; Michon J; Leverger G
Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
[TBL] [Abstract][Full Text] [Related]
12. Bilateral adrenal neuroblastoma is different.
Pederiva F; Andres A; Sastre A; Alves J; Martinez L; Tovar JA
Eur J Pediatr Surg; 2007 Dec; 17(6):393-6. PubMed ID: 18072022
[TBL] [Abstract][Full Text] [Related]
13. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.
Simon T; Spitz R; Faldum A; Hero B; Berthold F
J Pediatr Hematol Oncol; 2004 Dec; 26(12):791-6. PubMed ID: 15591897
[TBL] [Abstract][Full Text] [Related]
14. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
[TBL] [Abstract][Full Text] [Related]
15. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
[TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Matsuzaki A; Hara T; Taguchi T
J Pediatr Surg; 2009 Dec; 44(12):2253-7. PubMed ID: 20006005
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
Taggart DR; London WB; Schmidt ML; DuBois SG; Monclair TF; Nakagawara A; De Bernardi B; Ambros PF; Pearson AD; Cohn SL; Matthay KK
J Clin Oncol; 2011 Nov; 29(33):4358-64. PubMed ID: 21969516
[TBL] [Abstract][Full Text] [Related]
18. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
[TBL] [Abstract][Full Text] [Related]
19. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S
J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]